Litigation Readiness For Acquired Products | Kisaco Research

Products acquired through M&A often face litigation without the institutional knowledge needed to defend them. Inventors may be gone, records incomplete, and invention stories fragmented - all of which become critical weaknesses once litigation begins. This presentation will provide practical insight on how to prepare acquired products for litigation before disputes arise.

Speaker(s): 

Author:

Andrea Tiglio

Exec Director, Assistant GC of IP
Jazz Pharmaceuticals

Andrea Tiglio

Exec Director, Assistant GC of IP
Jazz Pharmaceuticals

Author:

Erin Bell

Senior Corporate Counsel
Premier Inc

Erin Bell

Senior Corporate Counsel
Premier Inc

Author:

Kamleh Nicola

Partner
Marks & Clerk

Kamleh Nicola is a partner at Marks & Clerk and Co-Head of the firm’s Litigation practice in Canada. Her intellectual property litigation practice centers around patent, trademark, and copyright disputes. Though her client base is broad in scope, she specializes in Health and Life Sciences, working with domestic and multinational pharmaceutical, biopharma, and MedTech organizations. Kamleh is particularly knowledgeable on matters involving Canada’s patent linkage regimes, health regulatory and related compliance, and trade secrets.

 

Kamleh Nicola

Partner
Marks & Clerk

Kamleh Nicola is a partner at Marks & Clerk and Co-Head of the firm’s Litigation practice in Canada. Her intellectual property litigation practice centers around patent, trademark, and copyright disputes. Though her client base is broad in scope, she specializes in Health and Life Sciences, working with domestic and multinational pharmaceutical, biopharma, and MedTech organizations. Kamleh is particularly knowledgeable on matters involving Canada’s patent linkage regimes, health regulatory and related compliance, and trade secrets.

 

Author:

Kassie Helm

Partner
Dechert

Kassie Helm

Partner
Dechert

Author:

Raymond Parker III

Vice President - Global Lead IP Dispute Resolution
BioNtech

Raymond Parker III

Vice President - Global Lead IP Dispute Resolution
BioNtech
Time: 
11:15am – 12:00pm
Agenda Track No.: 
Track 3
Session Type: 
Track
Force Inline Description: 
0